Expert makes case for patient-specific dosimetry

06/13/2013 | MolecularImaging.net

To improve patient diagnosis and therapy, there is a need to advance patient-specific dosimetry, said Hal Anger Lectureship & Award lecturer Michael G. Stabin, a researcher at Vanderbilt University School of Medicine, in a message at the SNMMI Annual Meeting. "We have a new generation of dose phantoms and selection of sophisticated [dose planning tools and] methods ... and it's time to incorporate dose calculations into clinical therapy planning ... Our understanding of radiobiology is undergoing profound change. We will be rewriting history soon," Stabin said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI